Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02676882 · ClinicalTrials.gov registry record · NA
EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy
A NA study of Pregnancy and Depressive Disorder, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT02676882: Completed NA study of Pregnancy and Depressive Disorder, sponsored by Massachusetts General Hospital.
NCT02676882 is a NA study of Pregnancy and Depressive Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 25 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02676882, a NA study of Pregnancy and Depressive Disorder, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effectiveness of the EnBrace HR prenatal supplement in preventing depression in women with a history of depression who have decided to stop taking antidepressants during their pregnancy, or treating women who are currently in a depressive episode while pregnant or planning pregnancy.
Primary Outcome
Evidence of recurrence of major depression episode, as defined by the Mini-International Neuropsychiatric Interview (MINI) mood module and/or research clinician interview. The MINI is a brief, validated structured clinical interview used for diagnostic purposes for DSM-IV and ICD-10 psychiatric disorders in clinical trials. The interview is performed by a licensed study physician and takes about 15 minutes. The MINI is divided into modules corresponding to diagnostic categories, and questions ar
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT EnBrace HR
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-01-24 |
| Est. Completion | 2018-11-30 |
| Phase | NA |
What the finished NCT02676882 record still lists
NCT02676882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which EnBrace HR is the first listed.
NCT02676882 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02676882 about?
NCT02676882 is a clinical study titled "EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy". The purpose of this study is to assess the effectiveness of the EnBrace HR prenatal supplement in preventing depression in women with a history of depression who have decided to stop taking antidepressants during their pregnancy, or treating women who are currently in a depressive episode while preg...
What is the current status of trial NCT02676882?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-01-24. Estimated completion is 2018-11-30.
What conditions does trial NCT02676882 study?
This clinical trial studies the following conditions: Pregnancy, Depressive Disorder.
What interventions are being tested in trial NCT02676882?
The interventions under investigation include: EnBrace HR (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02676882?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02676882 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02676882's enrollment target sits among peer trials
25 176th of 191 higher than 14 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI